New Drug Classes with Novel Mechanisms of Action for HIV, Hepatitis B, and Tuberculosis
This grant opportunity is focused on advancing drug development and preclinical testing for HIV, HBV, and Mtb, aiming to overcome challenges like drug resistance and limited treatment efficacy. The National Institutes of Health (NIH) seeks proposals for innovative strategies, potentially utilizing AI and machine learning, to help develop therapies. Fast Track proposals are accepted, but Direct…
Fast Track Proposals will be accepted.\nDirect-to-Phase II proposals will not be accepted.\nNumber of anticipated awards: 3-7\nBudget (total costs):\nPhase I: $ 300,000 per year for up to 2 years\nPhase II: $ 2 million total for up to 3 years\nBackground\nFor more than three decades, NIH has fos…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers